3 1 form3-042501_llc.txt FORM 3 U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940 -------------------------------------------------------------------------------- 1. Name and Address of Reporting Person* ORBIMED ADVISORS, LLC -------------------------------------------------------------------------------- (Last) (First) (Middle) 767 Third Avenue, 6th Floor -------------------------------------------------------------------------------- (Street) New York NY 10010 -------------------------------------------------------------------------------- (City) (State) (Zip) -------------------------------------------------------------------------------- 2. Date of Event Requiring Statement (Month/Day/Year) November 15, 2000 -------------------------------------------------------------------------------- 3. IRS Identification Number of Reporting Person, if an Entity (Voluntary) -------------------------------------------------------------------------------- 4. Issuer Name and Ticker or Trading Symbol Depomed Inc. (DMI) -------------------------------------------------------------------------------- 5. Relationship of Reporting Person to Issuer (Check all applicable) [_] Director [X] 10% Owner [_] Officer (give title below) [_] Other (specify below) -------------------------------------------------------------------------------- 1. Name and Address of Reporting Person* ISALY, SAMUEL D. -------------------------------------------------------------------------------- (Last) (First) (Middle) 767 Third Avenue, 6th Floor -------------------------------------------------------------------------------- (Street) New York NY 10010 -------------------------------------------------------------------------------- (City) (State) (Zip) -------------------------------------------------------------------------------- 2. Date of Event Requiring Statement (Month/Day/Year) November 15, 2000 -------------------------------------------------------------------------------- 3. IRS Identification Number of Reporting Person, if an Entity (Voluntary) -------------------------------------------------------------------------------- 4. Issuer Name and Ticker or Trading Symbol Depomed Inc. (DMI) -------------------------------------------------------------------------------- 5. Relationship of Reporting Person to Issuer (Check all applicable) [_] Director [X] 10% Owner [_] Officer (give title below) [_] Other (specify below) -------------------------------------------------------------------------------- 6. If Amendment, Date of Original (Month/Day/Year) -------------------------------------------------------------------------------- 7. Individual or Joint/Group Filing (Check applicable line) [_] Form Filed by One Reporting Person [X] Form Filed by More than One Reporting Person ================================================================================ Table I -- Non-Derivative Securities Beneficially Owned ================================================================================
3. Ownership Form: 2. Amount of Securities Direct (D) or 1. Title of Security Beneficially Owned Indirect (I) 4. Nature of Indirect Beneficial Ownership (Instr. 4) (Instr. 4) (Instr. 5) (Instr. 4) ------------------------------------------------------------------------------------------------------------------------------------ Common Stock N/A--No beneficial ownership pursuant to Rule 16a-1(a)(2) (See note 1) ------------------------------------------------------------------------------------------------------------------------------------ ====================================================================================================================================
* If the Form is filed by more than one Reporting Person, see Instruction 5(b)(v). Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. ================================================================================ Table II -- Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) ================================================================================
5. Owner- 3. Title and Amount of Securities ship Underlying Derivative Security Form of 2. Date Exercisable (Instr. 4) Derivative and Expiration Date --------------------------------- 4. Conver- Security: (Month/Day/Year) Amount sion or Direct 6. Nature of ---------------------- or Exercise (D) or Indirect Date Expira- Number Price of Indirect Beneficial 1. Title of Derivative Exer- tion of Derivative (I) Ownership Security (Instr. 4) cisable Date Title Shares Security (Instr. 5) (Instr. 5) ------------------------------------------------------------------------------------------------------------------------------------ Series A Warrants 11/15/00 11/14/04 Common Stock 178,551 $5.50 p/s (I) See Note 1 ------------------------------------------------------------------------------------------------------------------------------------ Series B Warrants 11/15/00 11/14/04 Common Stock 178,551 $5.50 p/s (I) See Note 1 ------------------------------------------------------------------------------------------------------------------------------------ ====================================================================================================================================
Explanation of Responses: 1. Orbimed Advisors, LLC has investment management discretion over a number of collective investment funds investing in Depomed Inc. stock. It has no pecuniary interest in any of these securities or warrants. /s/Samuel D. Isaly Managing Member of OrbiMed Advisors, LLC April 25, 2001 -------------------------------------------------------------------------------- **Signature of Reporting Person Date ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Signature Page for Other Reporting Persons: SAMUEL D. ISALY By: /s/Samuel D. Isaly April 25, 2001 ----------------------------------------------------------------------------- Name: Samuel D. Isaly Date Designated Filer ---------------- OrbiMed Advisors, LLC Date of Event Requiring Statement--11/15/00 Issuer Name - DEPOMED INC. Trading Symbol-"DMI" Other Reporting Persons: ------------------------ Samuel D. Isaly 767 Third Avenue, 6th Floor New York, NY 10010